Barton Shane
SEC CIK 1836297 · EDGAR
BoughtSold
Most active insiders at BIOA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fortney Kristen | CEO, Dir | — | $4.22M |
| 2 | Barton Shane | Principal Accounting Off | — | $1.58M |
| 3 | RUBIN PAUL D | Chief Medical Off | — | $1.46M |
| 4 | GOLDSTEIN DOV A MD | CFO | — | $531.8K |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | BioAge Labs, Inc. | Barton Shane | Principal Accounting Off | M - OptEx | $6.58 | +59.9K | 20.2K | New | +$394.6K |
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | BioAge Labs, Inc. | Barton Shane | Principal Accounting Off | S - Sale+OE | $25.20 | -62.6K | 0 | -100% | -$1.58M |
| 2025-03-10 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Barton Shane | Principal Accounting Off | P - Purchase | $18.00 | +2,632 | 2,632 | New | +$47.4K | |
| D | 2023-06-09 | 2023-06-07 | DTIL | PRECISION BIOSCIENCES INC | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +6,060 | 27.5K | +28% | — |
| D | 2023-03-07 | 2023-03-03 | DTIL | PRECISION BIOSCIENCES INC | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +12.7K | 21.4K | +146% | — |
| D | 2022-06-09 | 2022-06-07 | DTIL | PRECISION BIOSCIENCES INC | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +6,061 | 8,720 | +228% | — |
| DM | 2022-03-07 | 2021-02-26+ | DTIL | PRECISION BIOSCIENCES INC | Barton Shane | VP, Corp. Ctrl | A - Grant | $5.70 | +2,659 | 2,659 | New | +$15.2K |
Purchase Sale Sale after option exercise All abbreviations